Presepsin acurately predicts mortality in patients undergoing transcatheter aortic valve implantation (TAVI)
Objective: The aim of this study was to assess whether Presepsin, a novel marker indicative for sepsis, has prognostic value in the postoperative outcome in patients after transcatheter aortic valve implantation (TAVI).